{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T18:48:48Z","timestamp":1692557328923},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1989,8,1]],"date-time":"1989-08-01T00:00:00Z","timestamp":617932800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[1989,8]]},"DOI":"10.1007\/bf00441941","type":"journal-article","created":{"date-parts":[[2004,11,12]],"date-time":"2004-11-12T03:02:39Z","timestamp":1100228559000},"page":"453-459","source":"Crossref","is-referenced-by-count":25,"title":["Blockade of acquisition of one-way conditioned avoidance responding by haloperidol and metoclopramide but not by thioridazine or clozapine: implications for screening new antipsychotic drugs"],"prefix":"10.1007","volume":"98","author":[{"given":"James R.","family":"Blackburn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony G.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/0361-9230(86)90181-4","volume":"16","author":"CA Altar","year":"1986","unstructured":"Altar CA, Wasley AM, Neale RF, Stone GA (1986) Typical and atypical antipsychotic occupancy of D2 and S2 receptors: An autoradiographic analysis in rat brain. Brain Res Bull 16:517?525","journal-title":"Brain Res Bull"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0163-1047(82)90903-7","volume":"36","author":"H Anisman","year":"1982","unstructured":"Anisman H, Irwin J, Zacharko RM, Tombaugh TN (1982) Effects of dopamine receptor blockade on avoidance performance: assessment of effects on cue-shock and response-outcome associations. Behav Neural Biol 36:280?290","journal-title":"Behav Neural Biol"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1600-0773.1982.tb01032.x","volume":"51","author":"J Arnt","year":"1982","unstructured":"Arnt J (1982) Pharmacological specificity of conditioned avoidance response inhibition in rats: inhibition by neuroleptics and correlation to dopamine receptor blockade. Acta Pharmacol Toxicol 51:321?329","journal-title":"Acta Pharmacol Toxicol"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1476-5381.1976.tb07636.x","volume":"56","author":"J Ashford","year":"1976","unstructured":"Ashford J, Jones BJ (1976) The effects of intra-amygdaloid injections of 6-hydroxydopamine on avoidance responding in rats. Br J Pharmacol 56:225?261","journal-title":"Br J Pharmacol"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1136\/bmj.291.6500.930","volume":"291","author":"DN Bateman","year":"1985","unstructured":"Bateman DN, Rawlins MD, Simpson JM (1985) Extrapyramidal reactions with metoclopramide. Br Med J 291:930?932","journal-title":"Br Med J"},{"key":"CR6","volume-title":"Per-spectives in aversively motivated behavior","author":"RJ Beninger","year":"1989","unstructured":"Beninger RJ (1989) The role of serotonin and dopamine in learning to avoid aversive stimuli. In: Archer T, Nilsson L-G (eds) Per-spectives in aversively motivated behavior. Eribaum, Hillsdale NJ (in press)"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/0091-3057(83)90290-3","volume":"18","author":"RJ Beninger","year":"1983","unstructured":"Beninger RJ, Phillips AG, Fibiger HC (1983) Prior training and intermittent retraining attenuate pimozide-induced avoidance deficits. Pharmacol Biochem Behav 18:619?624","journal-title":"Pharmacol Biochem Behav"},{"key":"CR8","first-page":"42","volume":"28","author":"JR Blackburn","year":"1987","unstructured":"Blackburn JR, Phillips AG, Fibiger HC (1987) Metoclopramide-induced disruption of conditioned avoidance responding. Can Psychol [Abstr] 28:42","journal-title":"Can Psychol [Abstr]"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0304-3940(87)90633-1","volume":"78","author":"CD Blaha","year":"1987","unstructured":"Blaha CD, Lane RF (1987) Chronic treatment with classical and atypical antipsychotic drugs differentially decreases dopamine release in striatum and nucleus accumbens in vivo. Neurosci Lett 78:199?204","journal-title":"Neurosci Lett"},{"key":"CR10","first-page":"975","volume":"20","author":"P Borenstein","year":"1965","unstructured":"Borenstein P, Bles G (1965) Effects cliniques et electoencephalographiques du metoclopramide en psychiatrie. Therapie 20:975?995","journal-title":"Therapie"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1523\/JNEUROSCI.05-09-02539.1985","volume":"5","author":"LA Chiodo","year":"1985","unstructured":"Chiodo LA, Bunney BS (1985) Possible mechanisms by which repeated clozapine administration differentially affects the activity of two subpopulations of midbrain dopamine neurons. J Neurosci 5:2539?2544","journal-title":"J Neurosci"},{"key":"CR12","first-page":"358","volume":"185","author":"BR Cooper","year":"1973","unstructured":"Cooper BR, Breese GR, Grant LD, Howard JL (1973) Effects of 6-hydroxydopamine treatments on active avoidance responding: evidence for involvement of brain dopamine. J Pharmacol Exp Ther 185:358?370","journal-title":"J Pharmacol Exp Ther"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/0024-3205(76)90205-8","volume":"18","author":"AB Davidson","year":"1976","unstructured":"Davidson AB, Weidley E (1976) Differential effects of neuroleptic and other psychotropic agents on acquisition of avoidance in rats. Life Sci 18:1279?1284","journal-title":"Life Sci"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0091-3057(74)90139-7","volume":"2","author":"HC Fibiger","year":"1974","unstructured":"Fibiger HC, Phillips AG, Zis AP (1974) Deficits in instrumental responding after 6-hydroxydopamine lesions of the nigro-neostriatal dopaminergic projection. Pharmacol Biochem Behav 2:87?96","journal-title":"Pharmacol Biochem Behav"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0014-2999(75)90114-4","volume":"30","author":"HC Fibiger","year":"1975","unstructured":"Fibiger HC, Zis AP, Phillips AG (1975) Haloperidol-induced disruption of conditioned avoidance responding: attenuation by prior training or by anticholinergic drugs. Eur J Pharmacol 30:309?314","journal-title":"Eur J Pharmacol"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/BF00421473","volume":"46","author":"J Gerlach","year":"1975","unstructured":"Gerlach J, Tharsen K, Fog R (1975) Extrapyramidal reactions and amine metabolites in cerebrospinal fluid during haloperidol and clozapine treatment of schizophrenic patients. Psychopharmacology 46:341?350","journal-title":"Psychopharmacology"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2165\/00003495-198325050-00002","volume":"25","author":"RA Harrington","year":"1983","unstructured":"Harrington RA, Hamilton CW, Brogden RN, Linkewich JA, Romankiewicz JA, Heel RC (1983) Metoclopramide: an updated review of its pharmacological properties and clinical use. Drugs 25:451?494","journal-title":"Drugs"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0024-3205(78)90039-5","volume":"23","author":"JL Howard","year":"1978","unstructured":"Howard JL, Large BT, Wedley S, Pullar IA (1978) The effects of standard neuroleptic compounds on the binding of 3H-spiroperidol in the striatum and mesolimbic system of the rat in vitro. Life Sci 23:599?604","journal-title":"Life Sci"},{"key":"CR19","first-page":"462","volume":"226","author":"LC Iorio","year":"1983","unstructured":"Iorio LC, Barnett A, Leitz FH, Houser VP, Korduba CA (1983) SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems. J Pharmacol Exp Ther 226:462?468","journal-title":"J Pharmacol Exp Ther"},{"key":"CR20","first-page":"279","volume":"132","author":"S Irwin","year":"1961","unstructured":"Irwin S (1961) Correlation in rats between the locomotor and avoidance suppressant potencies of eight phenothiazine tranquilizers. Arch Int Pharmacodyn Ther 132:279?286","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"CR21","first-page":"104","volume":"15","author":"PAJ Janssen","year":"1965","unstructured":"Janssen PAJ, Niemegeers CJE, Schellekens KHL (1965) Is it possible to predict the clinical effects of neuroleptic drugs (major tranquilizers) from animal data? I. ?Neuroleptic activity spectra? for rats. Arzneimittelforschung 15:104?117","journal-title":"Arzneimittelforschung"},{"key":"CR22","first-page":"805","volume":"29","author":"HL Klawans","year":"1968","unstructured":"Klawans HL (1968) The pharmacology of parkinsonism (a review). Dis Nerv Syst 29:805?816","journal-title":"Dis Nerv Syst"},{"key":"CR23","volume-title":"Diagnosis and treatment of psychiatric disorders","author":"DF Klein","year":"1980","unstructured":"Klein DF, Gittelman R, Quitkin F, Rafkin A (1980) Diagnosis and treatment of psychiatric disorders, 2nd edn. Williams and Williams, Baltimore","edition":"2nd edn."},{"key":"CR24","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0006-8993(84)91218-6","volume":"303","author":"GF Koob","year":"1984","unstructured":"Koob GF, Simon H, Herman JP, Le Moal M (1984) Neuroleptic-like disruption of the conditioned avoidance response requires destruction of both the mesolimbic and nigrostriatal dopamine systems. Brain Res 303:319?329","journal-title":"Brain Res"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0006-8993(87)90396-9","volume":"408","author":"RF Lane","year":"1987","unstructured":"Lane RF, Blaha CD (1987) Acute thioridazine stimulates mesolimbic but not nigrostriatal dopamine release: Demonstration by in vivo electrochemistry. Brain Res 408:317?320","journal-title":"Brain Res"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/0091-3057(75)90123-9","volume":"3","author":"JG Lenard","year":"1975","unstructured":"Lenard JG, Beer B (1975) Relationship of brain levels of norepinephrine and dopamine to avoidance behavior in rats after intraventricular administration of 6-hydroxydopamine. Pharmacol Biochem Behav 3:895?899","journal-title":"Pharmacol Biochem Behav"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF00426672","volume":"60","author":"T Ljungberg","year":"1979","unstructured":"Ljungberg T, Ungerstedt U (1979) Evidence that the different properties of haloperidol and clozapine are not explained by differences in anticholinergic potency. Psychopharmacology 60:303?307","journal-title":"Psychopharmacology"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/0091-3057(85)90025-5","volume":"23","author":"T Ljungberg","year":"1985","unstructured":"Ljungberg T, Ungerstedt U (1985) A rapid and simple behavioural screening method for simultaneous assessment of limbic and striatal blocking effects of neuroleptic drugs. Pharmacol Biochem Behav 23:479?485","journal-title":"Pharmacol Biochem Behav"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/j.1552-4604.1975.tb02368.x","volume":"15","author":"B Nakra","year":"1975","unstructured":"Nakra B, Bond AJ, Lader MH (1975) Comparative psychotropic effects of metoclopramide and prochlorperazine in normal subjects. J Clin Pharmacol 15:449?454","journal-title":"J Clin Pharmacol"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0028-3908(84)90219-3","volume":"23","author":"F Petty","year":"1984","unstructured":"Petty F, Mott J, Sherman AD (1984) Potential locus and mechanism of blockade of conditioned avoidance responding by neuroleptics. Neuropharmacology 23:73?78","journal-title":"Neuropharmacology"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/0091-3057(79)90328-9","volume":"10","author":"AG Phillips","year":"1979","unstructured":"Phillips AG, Fibiger HC (1979) Decreased resistance to extinction after haloperidol: implications for the role of dopamine in reinforcement. Pharmacol Biochem Behav 10:751?760","journal-title":"Pharmacol Biochem Behav"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/BF00408321","volume":"3","author":"D Posluns","year":"1962","unstructured":"Posluns D (1962) An analysis of chlorpromazine-induced suppression of the avoidance response. Psychopharmacologia 3:361?373","journal-title":"Psychopharmacologia"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0091-3057(84)90137-0","volume":"21","author":"A Robertson","year":"1984","unstructured":"Robertson A, MacDonald C (1984) Atypical neuroleptics clozapine and thioridazine enhance amphetamine-induced stereotypy. Pharmacol Biochem Behav 21:97?101","journal-title":"Pharmacol Biochem Behav"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0014-2999(85)90542-4","volume":"109","author":"A Robertson","year":"1985","unstructured":"Robertson A, MacDonald C (1985) Opposite effects of sulpiride and metoclopramide on amphetamine-induced stereotypy. Eur J Pharmacol 109:81?89","journal-title":"Eur J Pharmacol"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0014-2999(76)90119-9","volume":"39","author":"P Setler","year":"1976","unstructured":"Setler P, Sarua H, McKenzie G (1976) Differential attenuation of some effects of haloperidol in rats given scopolamine. Eur J Pharmacol 39:117?126","journal-title":"Eur J Pharmacol"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/0024-3205(82)90318-6","volume":"30","author":"AD Sherman","year":"1982","unstructured":"Sherman AD, Petty F, Sacquitne JL (1982) Regional aspects of the delay of acquisition conditioned avoidance responding by chlorpromazine. Life Sci 30:1811?1815","journal-title":"Life Sci"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/archpsyc.1974.01760130040006","volume":"31","author":"S Snyder","year":"1974","unstructured":"Snyder S, Greenberg D, Yamamura HI (1974) Antischizophrenic drugs and brain cholinergic receptors. Arch Gen Psychiatry 31:58?61","journal-title":"Arch Gen Psychiatry"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF00433055","volume":"71","author":"M Stanley","year":"1980","unstructured":"Stanley M, Lautin A, Rotrosen J, Gershon S, Kleinberg D (1980) Metoclopramide: antipsychotic efficacy of a drug lacking potency in receptor models. Psychopharmacology 71:219?225","journal-title":"Psychopharmacology"},{"key":"CR39","first-page":"281","volume-title":"Neuroleptics: neurochemical, behavioral and clinical perspectives","author":"CA Tamminga","year":"1983","unstructured":"Tamminga CA (1983) Atypical neuroleptics and novel antipsychotic drugs. In: Coyle JT, Enna SJ (eds) Neuroleptics: neurochemical, behavioral and clinical perspectives. Raven Press, New York, pp 281?295"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1126\/science.6136093","volume":"221","author":"FJ White","year":"1983","unstructured":"White FJ, Wang RY (1983) Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons. Science 221:1054?1057","journal-title":"Science"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1126\/science.566469","volume":"201","author":"RA Wise","year":"1978","unstructured":"Wise RA, Spindler J, DeWit H, Gerber GJ (1978) Neuroleptic-induced ?anhedonia? in rats: pimozide blocks reward quality of food. Science 201:262?264","journal-title":"Science"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1126\/science.185.4155.960","volume":"185","author":"AP Zis","year":"1974","unstructured":"Zis AP, Fibiger HC, Phillips AG (1974) Reversal by L-dopa of impaired learning due to destruction of the dopaminergic nigroneostriatal bundle. Science 185:960?962","journal-title":"Science"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00441941.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00441941\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00441941","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T00:38:18Z","timestamp":1554338298000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00441941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,8]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1989,8]]}},"alternative-id":["BF00441941"],"URL":"https:\/\/doi.org\/10.1007\/bf00441941","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989,8]]}}}